As COVID-19 multiplied across the globe in early 2020, IVD companies raced to provide testing solutions. However, rapid development of diagnostic solutions led in some cases to compromised reagent quality, causing confusion and concern amongst clinicians and lab professionals.
With this background, Erba Mannheim committed to develop reliable and affordable solutions to SARS-CoV-2 testing. First out have been the ErbaLisa IgG and IgM antibody ELISA kits. These were developed and manufactured by Calbiotech, Erba group’s immunoassay center of excellence in California.
Quality and performance were top priorities. The IgG kits use Spike protein antigens to ensure clinical relevance and specificity, and IgM kits use a combination of Spike and Nucleocapsid antigens. Performance and accuracy were extensively validated by multiple studies in universities and public/private laboratories. With CE mark and pending US EUA authorization, ErbaLisa COVID-19 assays gained approval by strict global regulatory bodies including Brazil’s ANVISA and ICMR in India.
Our commitment is to make quality diagnostic solutions affordable to growing labs across all emerging markets in Asia, LATAM, MEA, Eastern Europe and Russia. We believe these products answer the immediate needs and are proud to be helping in the fight against COVID-19.
Read more
Making SARS-CoV-2 testing available to labs everywhere
, /in Corona News, Product News /by 3wmediaAs COVID-19 multiplied across the globe in early 2020, IVD companies raced to provide testing solutions. However, rapid development of diagnostic solutions led in some cases to compromised reagent quality, causing confusion and concern amongst clinicians and lab professionals.
With this background, Erba Mannheim committed to develop reliable and affordable solutions to SARS-CoV-2 testing. First out have been the ErbaLisa IgG and IgM antibody ELISA kits. These were developed and manufactured by Calbiotech, Erba group’s immunoassay center of excellence in California.
Quality and performance were top priorities. The IgG kits use Spike protein antigens to ensure clinical relevance and specificity, and IgM kits use a combination of Spike and Nucleocapsid antigens. Performance and accuracy were extensively validated by multiple studies in universities and public/private laboratories. With CE mark and pending US EUA authorization, ErbaLisa COVID-19 assays gained approval by strict global regulatory bodies including Brazil’s ANVISA and ICMR in India.
Our commitment is to make quality diagnostic solutions affordable to growing labs across all emerging markets in Asia, LATAM, MEA, Eastern Europe and Russia. We believe these products answer the immediate needs and are proud to be helping in the fight against COVID-19.
Read more
Serological biomarkers for refractory celiac disease
, /in Autoimmunity & Allergy, Featured Articles, Gastrointestinal Disorders /by panglobalby Dr Hetty J. Bontkes
Type II refractory celiac disease (RCD-II) and enteropathy associated T-cell lymphoma (EATL) are rare but serious complications of adult onset celiac disease.
Read more
Medlab Asia
, /in Events /by 3wmediaOctober 28-30, 2020
Bangkok, Asia
www.medlabasia.com
(OLD) DxFLEX – Gain independent compensation
, /in No Category /by 3wmediaTwo types of photon detectors are used to amplify and then convert lightinto electronic signals in flow cytometry. The traditional detector is the photomultiplier tube (PMT). Avalanche Photodiodes (APD) are another type of photon detector and are used in the DxFLEX flow cytometer.
Nova Biomedical to Host Webinar on COVID-19 Bedside Glucose Management
, /in White Papers /by 3wmediaWaltham, MA–Nova Biomedical to host “COVID-19 Bedside Glucose Management: Risk of Ascorbic Acid and Hematocrit Interference,” a webinar led by Charbel Abou-Diwan, PhD, Director of Medical and Scientific Affairs, to help inform and support healthcare workers treating COVID-19 patients.
(OLD) Critical Thinking for Early Diagnosis of Prostate Cancer
, /in No Category /by 3wmediaThe best outcomes in cancer treatment can be achieved with early diagnosis. Prostate-specific antigen (PSA) is unique in that it is the only tissue-specific biomarker that can aid in the early diagnosis…